✦ LIBER ✦

Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life

✍ Scribed by Dr Kim A. Papp, James Signorovitch, Karthik Ramakrishnan, Andrew P. Yu, Shiraz R. Gupta, Yanjun Bao, Parvez M. Mulani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discontinuation of adalimumab treatment

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Impact of Active and Stable Psoriasis on

✍ Daudén, E.; Herrera, E.; Puig, L.; Sánchez-Carazo, J.L.; Toribio, J.; Perulero, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Spanish ⚖ 668 KB

Impact of Cancer-Related Symptom Synergi

✍ Karine A.S.L. Ferreira; Miako Kimura; Manoel J. Teixeira; Tito R. Mendoza; Jose 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 247 KB

ABT-874 versus methotrexate in moderate

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

PSS17 IMPACT OF ADALIMUMAB ON QUALITY OF

✍ D Guh; K Papp; C Lynde; N Bansback; W Zhang; H Qian; MJ Martel; A Goyette; H Tei 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Age-related effects on symptom status an

✍ Kathleen M. Nokes; Christopher Lance Coleman; Mary Jane Hamilton; Inge B. Corles 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 178 KB